STEGLUJAN 15 mg/1

Steglujan 15 mg/1 combines ertugliflozin and sitagliptin for managing type 2 diabetes. This oral medication supports blood sugar control. Learn about its uses, effects, and precautions.

Steglujan 15 mg/1 is a combination medication used to manage type 2 diabetes. It works by improving blood sugar control, often when diet and exercise alone are not enough. This medication is typically prescribed for adults with type 2 diabetes to help lower blood glucose levels. It is not intended for treating type 1 diabetes or diabetic ketoacidosis.

Common effects of Steglujan 15 mg/1 may include urinary tract infections, hypoglycemia, and upper respiratory tract infections. Some users may experience nausea, diarrhea, or constipation. These effects vary and are not exhaustive. Consult a healthcare provider for personalized advice.

Handle Steglujan 15 mg/1 with care, especially if you have a history of kidney problems, pancreatitis, or allergic reactions. Avoid alcohol and stay hydrated. Store at room temperature, away from moisture and heat. Always follow your healthcare provider's instructions.

Steglujan 15 mg/1 may interact with other medications, including insulin, sulfonylureas, and certain antibiotics. Alcohol can increase the risk of side effects. Inform your healthcare provider about all medications you are taking to avoid potential interactions.